Novan (NOVN) Posts Q3 Loss of $5.76/Share

Go back to Novan (NOVN) Posts Q3 Loss of $5.76/Share

Novan Reports Third Quarter 2016 Financial Results

November 14, 2016 9:29 AM EST

MORRISVILLE, N.C., Nov. 14, 2016 (GLOBE NEWSWIRE) -- Novan, Inc. (the Company or Novan) (NASDAQ: NOVN) today announced the Companys financial results for the third quarter of 2016. Total operating expenses for the three months ended Sept. 30, 2016, were approximately $17.5 million, which includes research and development, or R&D, expenses totaling approximately $15.0 million and general and administrative, or G&A, expenses totaling approximately $2.5 million. Total operating expenses for the three months ended Sept. 30, 2015, were approximately $5.6 million, which included R&D expenses totaling approximately $3.2 million and G&A expenses totaling approximately $2.4 million. The year-over-year... More

Novartis partners with prominent US health advocacy organizations to launch first social networking platform for heart failure patients and their loved ones

November 10, 2016 8:00 AM EST

EAST HANOVER, N.J., Nov. 10, 2016 /PRNewswire/ -- Novartis Pharmaceuticals Corporation announced today the launch of Together in HF (www.TogetherinHF.com) a social network for members of the heart failure (HF) community in partnership with national patient and professional organizations supporting heart health. Together in HF is the first social network for HF patients and caregivers to share their stories, and support and inspire each other.  Members can access HF information and other resources from leading patient and caregiver advocacy groups as well as professional medical associations.... More